HomeRNXT • NASDAQ
add
RenovoRx Inc
Previous close
$1.27
Day range
$1.14 - $1.25
Year range
$0.53 - $3.29
Market cap
20.41M USD
Avg Volume
45.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.78M | -18.11% |
Net income | -3.23M | -49.68% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.78M | 18.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.17M | -81.79% |
Total assets | 1.47M | -79.82% |
Total liabilities | 4.47M | 305.26% |
Total equity | -3.00M | — |
Shares outstanding | 16.87M | — |
Price to book | -4.54 | — |
Return on assets | -178.23% | — |
Return on capital | 296.76% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -3.23M | -49.68% |
Cash from operations | -2.05M | -22.13% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -2.05M | -258.17% |
Free cash flow | -1.32M | -49.74% |
About
Founded
2009
Headquarters
Website
Employees
8